Skip to main content
. 2023 May 4;9(5):e15886. doi: 10.1016/j.heliyon.2023.e15886

Fig. 13.

Fig. 13

Antibacterial activities of the Fe3O4 nanoparticles, PDAN, and some isoxazole-5(4H)-ones versus Escherichia coli and Staphylococcus aureus. 4c: 3-Methyl-4-(4-Ethoxybenzylidene) isoxazole-5 (4H)-one; 4d: 3-Methyl-4-(4-ethoxy benzylidene) isoxazole-5 (4H)-one; 4f: 3-Methyl-4-(3,4,5-trimethoxybenzylidene) isoxazole-5 (4H)-one; 4g: 3-Methyl-4-(4-(methylthio)benzylidene) isoxazole-5 (4H)-one; 4j: 3-Methyl-4-(4-hydroxy benzylidene) isoxazole-5 (4H)-one; 4n: 3-Methyl-4-(4-(dimethylamino)benzylidene)isoxazole-5(4H)-one; 4t:4-(naphthalen-1-ylmethylene)-3-phenylisoxazol-5(4H)-one; 4s: 3-methyl-4-(4-ethylbenzylidene)isoxazol-5(4H)-one.